Lichen planus in a patient treated with pembrolizumab for metastatic malignant melanoma

Clin Exp Dermatol. 2018 Apr;43(3):354-356. doi: 10.1111/ced.13315. Epub 2017 Dec 8.

Authors

J Denny¹, H Chong², V Akhras¹

Affiliations

¹ Department of Dermatology, St George's Hospital, London, UK.
² Department of Cellular Pathology, St George's Hospital, London, UK.

PMID: 29222829
DOI: 10.1111/ced.13315

No abstract available

Publication types

Case Reports

MeSH terms

Anti-Inflammatory Agents / therapeutic use
Antibodies, Monoclonal, Humanized / adverse effects*
Antineoplastic Agents, Immunological / adverse effects*
Clobetasol / therapeutic use
Humans
Lichen Planus / chemically induced*
Lichen Planus / drug therapy
Lichen Planus / pathology
Male
Melanoma / drug therapy*
Melanoma / secondary
Middle Aged
Prednisolone / therapeutic use

Substances

Anti-Inflammatory Agents
Antibodies, Monoclonal, Humanized
Antineoplastic Agents, Immunological
Prednisolone
Clobetasol
pembrolizumab